1.1801
Oncolytics Biotech Inc Aktie (ONCY) Neueste Nachrichten
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - The Malaysian Reserve
Oncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL Event - TipRanks
Key Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future Potential – Company AnnouncementFT.com - Financial Times
Cancer Surge Meets Funding Crunch as Breakthrough Biotechs Line Up Milestones in 2025 - Baystreet.ca
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - Benzinga
What analysts say about Oncolytics Biotech Inc. stockTremendous growth opportunities - Autocar Professional
Oncolytics Biotech Inc - Baystreet.ca
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
What drives Oncolytics Biotech Inc. stock priceDynamic profit expansion - Autocar Professional
Oncolytics Biotech Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com
Pancreas Cancer Becoming Top Focus for Biotech Co.? - streetwisereports.com
Oncolytics Biotech Regains Compliance With Nasdaq's Minimum Bid Price Rule - 富途牛牛
Oncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025 - TipRanks
Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules - The Globe and Mail
Oncolytics Biotech regains compliance with Nasdaq listing requirements - Investing.com
Oncolytics regains Nasdaq compliance - TipRanks
Oncolytics Biotech® Regains Compliance With Nasdaq Trading Rules - Barchart.com
Is Oncolytics Biotech Inc. a good long term investmentHigh-yield portfolio picks - jammulinksnews.com
How To Trade (ONC) (ONC:CA) - news.stocktradersdaily.com
Oncolytics names Jared Kelly as CEO - MSN
Oncolytics Biotech (ONCY) up more than 100% since Jun 23 - AInvest
What makes Oncolytics Biotech Inc. stock price move sharplyAnalyst Grade Signals - beatles.ru
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Cantech Letter
Emerging Oncology Breakthroughs Signal Opportunity Despite Research Funding Crunch - Baystreet.ca
Stocks In Play: Oncolytics Biotech Inc By Baystreet.ca - Investing.com Canada
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Oncolytics Biotech Unveils Promising Data on Pelareorep’s Efficacy Across Tumor Types - TipRanks
Oncolytics Biotech reports positive biomarker data for pelareorep - Investing.com
Oncolytics Biotech reports positive biomarker data for pelareorep By Investing.com - Investing.com South Africa
Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types - Barchart.com
(ONC) Trading Strategy and Analysis (ONC:CA) - news.stocktradersdaily.com
How the (ONC) price action is used to our Advantage (ONC:CA) - news.stocktradersdaily.com
Oncolytics Biotech Highlights Promising Pelareorep Data in Cancer Treatment - TipRanks
Oncolytics Biotech stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Cantech Letter
Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups - Baystreet.ca
USA News Group: Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - FinanzNachrichten.de
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):